Edition:
United States

Ocular Therapeutix Inc (OCUL.OQ)

OCUL.OQ on NASDAQ Stock Exchange Global Market

3.66USD
15 Feb 2019
Change (% chg)

$-0.01 (-0.27%)
Prev Close
$3.67
Open
$3.68
Day's High
$3.72
Day's Low
$3.65
Volume
44,849
Avg. Vol
116,801
52-wk High
$8.26
52-wk Low
$3.47

Chart for

About

Ocular Therapeutix, Inc. is a biopharmaceutical company focused on the development, manufacturing and commercialization of therapies for diseases and conditions of the eye using its proprietary hydrogel platform technology. Its lead product candidate, DEXTENZA (dexamethasone insert) for intracanalicular use, has completed Phase... (more)

Overall

Beta: --
Market Cap(Mil.): $181.90
Shares Outstanding(Mil.): 29.06
Dividend: --
Yield (%): --

Financials

  OCUL.OQ Industry Sector
P/E (TTM): -- 32.21 33.70
EPS (TTM): -2.12 -- --
ROI: -76.17 13.74 14.45
ROE: -96.45 16.49 15.96

Earnings vs. Estimates